Bardin Hill Management Partners’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-42,100
Closed -$4.14M 9
2025
Q2
$4.14M Buy
+42,100
New +$3.98M 2.44% 9

Other funds holding AMED

Bardin Hill Management Partners's AMED Position: Q3 2025 in Review

Bardin Hill Management Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 22,049 shares — an estimated $2.17M sold.

Bardin Hill Management Partners first reported a position in AMED in Q2 2023 and held it in 7 quarters. The position peaked at $12M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Bardin Hill Management Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Bardin Hill Management Partners sold 22,049 Amedisys shares in Q3 2025, an estimated $2.17M.
  • Bardin Hill Management Partners first reported a position in Amedisys in Q2 2023 and held it in 7 quarters.
  • Bardin Hill Management Partners's Amedisys position peaked at $12M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bardin Hill Management Partners's 13F filing for Q3 2025, filed 12 Nov 2025.